Champions Oncology, Inc. (CSBR) — QMA analysis
Sector: Healthcare · Market cap: 94 mil. $ · Price: $6.13 · Data as of 2026-07-24
Champions Oncology, Inc. má podprůměrné kompozitní skóre 36/100, čímž překonává 66 % z 23 312 sledovaných akcií. Nejvýraznější vrstvou je Analytici / transkripty, naopak nejslabší je Katalyzátory.
What 10 data layers say about CSBR
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamentální hodnota (FVS) | 39/100 |
| Kvalita zisků (EQS) | 5/100 |
| Technický trend (TSS) | 42/100 |
| Relativní síla (RS) | 36/100 |
| Momentum (USS) | 51/100 |
| Insider aktivita (IAS) | 0/100 |
| Dark pool / velrybí toky (WHS) | 48/100 |
| Institucionální 13F (IFS) | 55/100 |
| Analytici / transkripty (ATS) | 82/100 |
| Katalyzátory (XS) | 0/100 |
What does the QMA model currently show for Champions Oncology, Inc.?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
U CSBR se vrstvy rozcházejí — některé signály jsou silné (Analytici / transkripty), jiné slabé (Katalyzátory). Rozpor mezi vrstvami je sám o sobě informací: model nedává jednoznačný obrázek. Skóre je vstup do vašeho rozhodování, ne doporučení.
CSBR insider & smart money activity
Za poslední období evidujeme u CSBR více insiderských nákupů (6) než prodejů (1). QMA to označuje jako pozitivní insider aktivitu — popis datové vrstvy, ne pokyn k nákupu.
How CSBR compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for CSBR stock?
36.2/100 (grade D) as of 2026-07-24, fusing 10 data layers. An analytical score, not advice.
Are insiders buying CSBR stock?
Over the recent period: 6 buys and 1 sells. Assessment: STRONG_BUY.
Where can I see live CSBR data?
Live CSBR data and all 17,000+ stocks unlock with a free QMA account (30 days of Elite on signup).
Explore more — for free
The CSBR score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full CSBR analysis with all layers and live data? Open CSBR detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]